87 results
Page 2 of 5
8-K
EX-10.1
nt1cvp ea7
5 Nov 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
kb59y80f9onq21
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.2
gefr3z
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
8wsn80j1fpy tftq64f4
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.2
comhab0r5dnxnsi21c6b
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.1
1sn7zm3a9f6 u2ma5xvf
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K
EX-99.1
4twac9 zhybpq6ldfc2a
29 Sep 20
Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer
4:05pm
8-K
EX-10.1
xw1zdrat upxpd1u
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
8mzx1x4 h8wfcnlsx
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
1ikecdmyw8gwnu
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
e5jqsqcebd
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
fub12ie7mx4a0xiq
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm